Genocea Biosciences, Inc. (NASDAQ:GNCA), a company developing T cell-directed vaccines and immunotherapies, today reported recent corporate highlights and financial results for the third quarter ended September 30, 2014.
“During the third quarter we continued to advance our novel vaccine and immunotherapy pipeline.
Help employers find you! Check out all the jobs and post your resume.
